IL7R and systemic sclerosis: Figure 4 and Table 1 show that the frequency of SSc patients showing abnormal expression of CD39 and/or CD127 molecules within patients with altered CD8+ Treg function was more than twice that observed in patients with normal CD8+ Treg activity.